Correlation Between Visa and VanEck Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Visa and VanEck Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and VanEck Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and VanEck Biotech ETF, you can compare the effects of market volatilities on Visa and VanEck Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of VanEck Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and VanEck Biotech.

Diversification Opportunities for Visa and VanEck Biotech

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between Visa and VanEck is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and VanEck Biotech ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VanEck Biotech ETF and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with VanEck Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VanEck Biotech ETF has no effect on the direction of Visa i.e., Visa and VanEck Biotech go up and down completely randomly.

Pair Corralation between Visa and VanEck Biotech

Taking into account the 90-day investment horizon Visa Class A is expected to generate 0.63 times more return on investment than VanEck Biotech. However, Visa Class A is 1.58 times less risky than VanEck Biotech. It trades about -0.18 of its potential returns per unit of risk. VanEck Biotech ETF is currently generating about -0.22 per unit of risk. If you would invest  28,121  in Visa Class A on January 25, 2024 and sell it today you would lose (710.00) from holding Visa Class A or give up 2.52% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Visa Class A  vs.  VanEck Biotech ETF

 Performance 
       Timeline  
Visa Class A 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Very Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Visa is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
VanEck Biotech ETF 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VanEck Biotech ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental drivers, VanEck Biotech is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.

Visa and VanEck Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Visa and VanEck Biotech

The main advantage of trading using opposite Visa and VanEck Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, VanEck Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VanEck Biotech will offset losses from the drop in VanEck Biotech's long position.
The idea behind Visa Class A and VanEck Biotech ETF pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities